Double sequential external defibrillation for refractory ventricular fibrillation
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Double sequential external defibrillation for refractory ventricular fibrillation
-
ナレーター：
-
著者：
https://drive.google.com/file/d/11TsKmprFBBE5diEOlTzpxawsFig4SwVq/view?usp=sharing
Cheskes S, McLeod SL. Double sequential external defibrillation for refractory ventricular fibrillation: the science, the controversies and the future. J Electrocardiol. 2025 Jul-Aug;91:154046. doi: 10.1016/j.jelectrocard.2025.154046. Epub 2025 Jun 4. PMID: 40483934.
The provided source explores the scientific evidence and implementation of double sequential external defibrillation (DSED) for patients with refractory ventricular fibrillation. Drawing heavily from the DOSE-VF trial, the text explains that applying two rapid shocks using different pad orientations significantly improves neurological survival compared to standard methods. It addresses common clinical controversies, such as the rare risk of equipment damage and the comparative efficacy of changing electrode vectors. The authors also highlight how increased current delivery and reduced time spent in cardiac arrest contribute to better patient outcomes. Finally, the source outlines future research directions, including the potential for artificial intelligence to predict which patients require advanced shock strategies.